SAN DIEGO ENTREPRENEURS EXCHANGE’s Post

Semble Secures £12m in Series B Funding 🚀 Big news! We’ve just secured £12 million in our Series B round. Today, we’re proud to support over 10,000 healthcare professionals across 70+ specialties, improving care for 7 million patients. With this funding, we’re geared up to expand our impact, bringing even more value to healthcare professionals and their patients. This boost will fuel our investment in cutting-edge workflow automation and seamless integrations—tools that empower healthcare professionals by freeing up time and improving connection points across the healthcare landscape. We believe these innovations will lead to real, measurable improvements in patient outcomes. “At Semble, amplifying the impact of healthcare professionals is at our core,” says Christoph Lippuner, Semble's CEO. “This funding will help bring Semble to even more professionals, allowing them to focus more on patient care. We’re excited to position Semble at the forefront of AI-driven solutions in healthcare.” Thank you to Mercia Ventures, Octopus Ventures, Smedvig Ventures and Triple Point for believing in our mission. Together, we're driving forward a more connected healthcare ecosystem. And a heartfelt thank you to our incredible customers - your feedback and partnership shape everything we do. With you we’re making healthcare better, together. Here’s to the next chapter! 🌍💙 

Introducing the visionaries behind Axmed: Meet Felix Ohnmacht, Ph.D., the fervent co-founder at the heart of Axmed's mission. But who are the individuals behind this innovative venture, and what motivated them to embark on this journey? "It’s a story of good fortune and freedom, really," Felix says. For him, the decision to start Axmed was rooted in a deep, lifelong appreciation for the ingenuity and resilience of people in Low- and Middle-Income Countries (LMICs). Already in his childhood, Felix explains, he was captivated by communities rich in human-centered values and a knack for experimentation. Inspired by great leaders and mentors in LMICs, he harbored a dream of leveraging his skills to create outsized impact, to meaningfully transform healthcare for those in need through social business. "That company didn't exist, at least not how I imagined it, so we created it," Felix says. When the three co-founders decided to establish Axmed, it wasn't merely about identifying gaps in healthcare delivery; it was about recognizing and supporting the tremendous potential for innovative, sustainable solutions to emerge from within LMICs. It was about transcending short-term interests to increase the accessibility and affordability of medicines, with a strong commercial backbone. "As a technology company, we can push scalability that fundamentally levels the economic playing field and enables real competition on real opportunities," Felix explains. "That's what healthcare needs today, and it has the potential to relieve millions from health challenges so they can enjoy more freedom to thrive." Felix' vision for Axmed is ambitious yet simple: to establish a beacon of change – a new kind of company exemplifying that prioritizing the patient and the public is key to building a thriving business. "Axmed is not just a platform; it's a movement," he declares. "I believe real leadership starts when human beings are in service of others, and the same applies for companies, too. This is where I see Axmed - not just as the world's leading medicines marketplace, but as a trailblazer in ethical business practices and social leadership. In the next weeks, we will introduce Co-Founders Emmanuel Akpakwu and Sofía Radley-Searle - if you have any questions for them about Axmed, simply leave a comment! #Leadership #AccessToMedicine #LeadershipJourney

Be sure to check out the latest episode of Medtech Talk! This month, host Geoff Pardo and FIRE1 CEO Conor Hanley, PhD discuss Hanley’s experiences on raising capital at BiancaMed, how he keeps investors on the same page, and keeping an open mind to different perspectives from other people. He also delves into his viewpoint on patient compliance, what attracted him to healthcare in the first place, and more. https://bit.ly/3UBWqib

Despite the broader slow-down in VC funding, medtech saw over 20 % growth in deal value in Q1, according to the latest data from Pitchbook 📈 One good thing that could come out of this cooling period, is an increased focus on healthcare and medtech from venture capitalists. Perhaps one day we'll see more VC investments in human health than in ad delivery 📺⚕️ Wouldn't that be something? 🤞 #MedicalDevices #Medtech #InnovationInHealthcare #VentureCapital #HealthTech #Ophthalmology

This week on the The Scrubbed In Show, Meri Beckwith (Co-Founder Lindus Health) shares his journey from the world of investing to breaking the bottlenecks when it comes to clinical trials as he builds the anti-CRO for life science pioneers. We discussed: 🔄 Transitioning from venture capital into healthtech 💼 Investor vs Founder Traits, Personality and Mindset 🌱 The origin story of Lindus Health 🏗️ The first few days/weeks of building Lindus Health 🚧 Barriers to entering the pharma industry as a new startup 🔒 Securing the first clinical trial with Habitual 🍾 The bottle necks of clinical trials 🔍 The process of recruiting patients for clinical trials ❌ Where central organisations and institutions go wrong for clinical trials 🤖 The role of AI in the pharma industry 💰 Fundraising a $18m Series A with investments from the likes of Peter Thiel 🔒 How to prevent being replaced by the board and investors 🏢 How to build a healthy culture and team 🤝 How to become a great CEO and deal with co-founder conflicts 💊 Why do pharma need CROs for clinical trials and why become the anti-CRO Link in the comments!

✅Our healthcare report and market map are finally live✅ Over the past several months, I have shared with anyone who would listen that Michael Cardamone and I were in conversation with innovation executives across four of the top healthcare systems in the U.S. including Mayo Clinic Ventures, Hackensack Meridian Health, Cone Health Ventures, and University Hospitals Ventures to understand current strategies and priorities in order to hone in on our investment thesis. The goal was to arm healthtech founders with the inside perspective on the critical investment areas for US hospitals to help establish product-market fit and solve the industry's most pressing challenges. Links to download the report, check out the market map, and submit your company are all in the comments. Thank you to our contributing experts Shai Ran Sapir, Technology Development Manager at Mayo Clinic Ventures, Sandra Powell-Elliott, Chief Innovation and Commercialization Officer at Hackensack Meridian Health, David Heenan, Managing Director at Cone Health Ventures, and Matthew Zenker, Director of Deal Flow and Investments at University Hospitals Ventures. #healthcare #innovation #healthtech #earlystage #healthtechfounders #healthcarestartups

Last week, I had the privilege of spending time at The MedTech Conference, and am excited to share some of the impactful moments that made it so valuable. 🎤 Insight from FDA Leadership Hearing directly from Michelle Tarver, MD, PhD, the new acting center Director of CDRH, about her strategic priorities for FDA was not only enlightening but will shape the medtech landscape for years to come. 💼 Investor Meetings with Real Depth Unlike some investment events where conversations can feel rushed, I had the opportunity to engage in meaningful 1:1 discussions with investors. At this conference, they truly took the time to dive into Vibrato’s story, offering valuable feedback, openly sharing their fund goals, and collaborating on next steps—sometimes for over an hour! 🤝 Connecting with Peers and Industry Leaders It was energizing to reconnect with fellow CEOs from across the country. Sharing insights on how they are tackling common medtech challenges sparked fresh ideas. And rubbing shoulders with CEOs of multi-billion-dollar companies provided a unique perspective on what they prioritize when planning for growth. 🍽️ Dinner with a Former Senator A special dinner with a former senator offered a rare chance for candid discussion on how we can practically advance medtech, regardless of election outcomes. Conversations like these help us streamline processes and ensure innovation keeps moving forward. 🏆 A Tribute to Caroll H. Neubauer One of the most moving moments was watching Carol Neubauer receive a Lifetime Achievement Award. His journey in medtech, both professionally and personally, was inspiring and a testament to the commitment to patients that our industry stands for. A huge thanks to AdvaMed for organizing such an incredible event. The enthusiasm, commitment to patients, and passion for innovation in our industry were palpable. Looking forward to applying these insights and driving forward with Vibrato Medical, Inc.’s mission! P.S. Was too busy to take photos 📸, but gave a couple of interviews—so stay tuned for some videos from the conference! 🎥

🎉 We’re thrilled to share some news! We have just closed a funding round and welcome three new co-founders to the leadership team 🎉 After 1,5 years of launching our new product, patient relationship and clinical data management platform, we have gained 28% market share in Estonia and earned high praise, an average 4,8/5 from our clients. This new financing round allows us to keep building the best product for doctors, nurses and patients and to expand to new markets. FIRSTPICK, Change Ventures, HEARTFELT_VC as well as previous investors invest 700 000 EUR in this financing round, positioning us for accelerated growth and expansion. In line with this new chapter, three long-term team members, Helena Volmer (in charge of operations and sales), Dr. Andres Lasn (medical director) and Keir Volas (technology and product lead) join Liis as co-founders. “We are excited to expand our Estonian portfolio with the addition of Certific. The outstanding team behind Certific, led by Liis, Helena, Andres, and Keir, brings deep expertise and a truly innovative approach to digital health solutions. They are tackling a critical challenge in the healthcare industry—reducing the documentation burden on clinicians—based on their first-hand experiences. We are proud to co-lead this round and support them in building another category-defining company from the Baltics,” commented Andra Bagdonaite, partner at Lithuanian VC firm FIRSTPICK.  “The idea for the product came from real life as I saw the existing solutions didn’t solve the inefficiencies in patient-doctors communication and just caused more administrative burden. I’m excited to join Certific as a co-founder and to help take this rocket ship to the next level and make the lives of patients and healthcare workers around the world a little bit easier,”  explains Dr Andres Lasn, Medical Director and former family physician who is joining Certific as a co-founder. The original co-founders Taavet Hinrikus and Jack Kreindler, have ended their tenure as operationally active co-founders but remain as advising investors in Certific. Taavet Hinrikus says that healthtech as an industry is quite conservative and tough and Certific has seen its fair share of challenges along the way, including a radical pivot. “The current team has proven to be relentless in their goal of building radically better solutions for the healthcare industry and I’m excited to see the impact they are yet to make,” Taavet Hinrikus, initial co-founder and investor. We couldn’t be more excited about the next phase in Certific’s journey where we can keep building, growing and expanding to additional markets!

Cercle Raises $6M to Advance Women’s Healthcare Using Data-driven Insights Cercle Health, a California-based health tech company focusing on transforming women’s healthcare data at scale into critical insights for optimal patient service and business operations, has raised $6 million in seed funding. The funding round was spearheaded by Outsiders Fund, with contributions from CGHealth Ventures, Rogue Women's Fund, and FemHealth Ventures. Existing investors Sheryl Sandberg and Tom Bernthal’s SBVP fund also joined the financing round alongside other angel investors. Co-founded in 2020 by Juan Carlos Riveiro, Andreas Melder, Liya Sharif Lancia, the company developed an AI-driven healthcare insight platform, Cercle Biomedical Graph™, specifically designed to unlock women’s healthcare data at scale for use by healthcare providers to deliver personalized care and optimize business operations. Read more: https://lnkd.in/g8y3Nv5u #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

CopilotIQ and Biofourmis Merge to Transform In-Home Care - CopilotIQ, focused on chronic care for older adults, and Biofourmis, a global provider of in-home solutions, merge to create an AI-driven platform. - The platform delivers care across the full spectrum, including pre-surgical, acute, post-acute, and chronic care for hospitals, payors, and health systems. - The merger helps to streamlines operations for hospitals and payors with a unified platform and offer single technology integration. - The merger is backed by leading investors General Atlantic, Openspace Ventures, and Bessemer Venture Partners. How does the CopilotIQ and Biofourmis merger revolutionise in-home healthcare with AI-driven, personalised care? Come to our SME Capital Entrepreneurship Preview (SCEP) for the answers: Date: 20 November 2024  Time: 9am - 4pm You will get to: - Increase your company’s profitability and value💸 - Develop investor attractive business model with compelling value proposition 📈    - Achieve success in equity fundraising 💰 Register via this link:   https://lnkd.in/gP6abxaq This exclusive event is for members only. Limited seats are available. Whatsapp to 87211919 for enquiries. #askpif #capitalmarkets #capitalentrepreneurship #PIFCapital